이상반응 보고
| VAERS ID | 1624730 |
|---|---|
| 성별 | 여성 |
| 나이 | |
| 주 코드 | FR |
| 제약회사 | PFIZER\BIONTECH |
| 로트 번호 | |
| 예방접종 횟수 | |
| 접종일 | 2021-07-29 |
| 발병일 | 2021-07-29 |
| 상태 |
증상
- 임신 중 모성 노출(Maternal exposure during pregnancy)
- 임신 중 출혈(Haemorrhage in pregnancy)
이환 중 질병
지병
기타 의료
이전 예방접종
알레르기
임상 검사
증상 상세
Haemorrhage in early pregnancy; Vaccine exposure during pregnancy/5 + 3 pregnant; This is a spontaneous report from a contactable consumer (patient) downloaded from the regulatory authority-WEB.
The regulatory authority number is FI-FIMEA-20213805.
A 35-year-old pregnant female patient received bnt162b2 (COMIRNATY), via an unspecified route of administration on 29Jul2021 08:50 (Batch/Lot Number: UNKNOWN) as single dose (at the age of 35-years-old) for COVID-19 immunisation.
Medical history was not reported.
The patient did not have concomitant medications.
On 29Jul2021, the patient experienced haemorrhage in early pregnancy and vaccine exposure during pregnancy.
The events were further described as follows: The patient got the vaccine in the morning at 08:40 and at 17:40 she noticed blood in her pants.
The patient was 5 (weeks) + 3 pregnant, but she thinks she was going to have a miscarriage.
Haemorrhage in early pregnancy was considered serious, medically significant by the regulatory authority.
The outcome of the event was unknown.
No follow-up attempts are possible; information about lot/batch number cannot be obtained.
No further information is expected.